Skip to main content
Clinical Trials/NCT02292381
NCT02292381
Completed
Not Applicable

Blood Flow Regulation in Glaucoma

Medical University of Vienna1 site in 1 country120 target enrollmentApril 2014
ConditionsGlaucoma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Glaucoma
Sponsor
Medical University of Vienna
Enrollment
120
Locations
1
Primary Endpoint
Optic nerve head blood flow
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Glaucoma is one of the leading causes for blindness in industrialized countries. It is characterized by a progressive loss of retinal ganglion cells, morphological changes in the optic nerve head and a characteristic loss of visual field. Although increased intraocular pressure has been identified as the major risk factor for the development and the progression of the disease it has been speculated for a long time that impaired ocular blood flow may contribute to the pathogenesis of the disease. This concept has been supported by several epidemiological studies showing that low ocular perfusion pressure and small retinal vessel caliber are associated with the disease.

The proposed study tests the hypothesis that patients with glaucoma have reduced total retinal blood flow as compared to healthy subjects. Additionally, autoregulation of blood flow will be investigated during an increase in ocular perfusion pressure. This is of importance because it may clarify the degree of vascular involvement in glaucoma.

Registry
clinicaltrials.gov
Start Date
April 2014
End Date
November 28, 2016
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Gerhard Garhofer

Assoc. Prof. Univ. Doz. Dr.

Medical University of Vienna

Eligibility Criteria

Inclusion Criteria

  • Patients with open angle glaucoma:
  • Diagnosis of manifest open angle glaucoma as defined as pathological optic disc appearance, glaucoma hemifield test outside normal limits and/or untreated intraocular pressure ≥ 21 mmHg on at least three measurements in the medical history. Mean deviation in the visual field test \< 10 decibel
  • Healthy control subjects:
  • normal ophthalmic findings and intraocular pressure \< 20 mmHg on at least three measurements
  • no evidence of increased intraocular pressure in the medical history
  • no signs of glaucomatous damage in the optic disc or the glaucoma hemifield test

Exclusion Criteria

  • Presence or history of a severe medical condition as judged by the investigator
  • Abuse of alcoholic beverages
  • Participation in a clinical trial in the 3 weeks preceding the study
  • Exfoliation glaucoma
  • Pigmentary glaucoma
  • Secondary glaucoma
  • Ocular hypertension
  • History of acute angle closure
  • Intraocular surgery within the last 6 months
  • History of epilepsia

Outcomes

Primary Outcomes

Optic nerve head blood flow

Time Frame: once

Secondary Outcomes

  • Retinal blood flow(once)

Study Sites (1)

Loading locations...

Similar Trials